doi: 10.1002/jmv.1890280103.
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein
Affiliations
- PMID: 2723618
- DOI: 10.1002/jmv.1890280103
Item in Clipboard
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein
J Med Virol.
1989 May.
Abstract
A peptide was synthesized containing the entire 55 amino acid residue sequence of the hepatitis B virus (HBV) surface antigen preS2 region (ad subtype). The unconjugated peptide was inoculated into four chimpanzees. Following multiple injections, all of the animals developed specific antipeptide antibodies that reacted with intact surface antigen particles bearing the preS2 moiety. All four peptide-inoculated animals were found to be protected from infection after intravenous challenge with live HBV of either the ad or ay subtypes.
Similar articles
-
Anti-PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2 + S vaccine.J Med Virol. 1990 Feb;30(2):146-50. doi: 10.1002/jmv.1890300213. J Med Virol. 1990. PMID: 2313274
-
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.Proc Natl Acad Sci U S A. 1986 Dec;83(23):9174-8. doi: 10.1073/pnas.83.23.9174. Proc Natl Acad Sci U S A. 1986. PMID: 3466181 Free PMC article.
-
Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.Acta Virol. 1996 Nov-Dec;40(5-6):273-9. Acta Virol. 1996. PMID: 9171455
-
Subunit, recombinant and synthetic hepatitis B vaccines.Scand J Gastroenterol Suppl. 1985;117:27-38. doi: 10.3109/00365528509092225. Scand J Gastroenterol Suppl. 1985. PMID: 3912963 Review.
-
The application of molecular biology to the development of novel vaccines.Adv Exp Med Biol. 1989;251:83-98. doi: 10.1007/978-1-4757-2046-4_7. Adv Exp Med Biol. 1989. PMID: 2532858 Review.
Cited by
-
Recombinant avirulent salmonellae as oral vaccine carriers.Infection. 1992 Jan-Feb;20(1):1-8. doi: 10.1007/BF01704884. Infection. 1992. PMID: 1563805 Review. No abstract available.
-
Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.J Virol. 1990 Mar;64(3):1290-7. doi: 10.1128/JVI.64.3.1290-1297.1990. J Virol. 1990. PMID: 1689393 Free PMC article.
-
Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Med Microbiol Immunol. 2015 Feb;204(1):39-55. doi: 10.1007/s00430-014-0373-y. Epub 2014 Dec 19. Med Microbiol Immunol. 2015. PMID: 25523195 Review.
-
Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens.J Virol. 1992 Feb;66(2):1241-5. doi: 10.1128/JVI.66.2.1241-1245.1992. J Virol. 1992. PMID: 1309901 Free PMC article.
-
The humoral immune response in acute and chronic hepatitis B virus infection.Springer Semin Immunopathol. 1995;17(2-3):149-66. doi: 10.1007/BF00196163. Springer Semin Immunopathol. 1995. PMID: 8571166 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
